Deoxyadenosine

Deoxyadenosine

SCHEMBL1969830

Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1.O=P(O)(O)O

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Deoxyadenosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 known ✓ P27487 1/20 0.57
POLB P06746 1/20 0.68
HIF1A Q16665 1/20 0.65
ENPP1 P22413 3/20 0.65
P2RY1 P47900 1/20 0.65
SMN1; SMN2 Q16637 2/20 0.64
PNP P00491 1/20 0.64
LMNA P02545 1/20 0.64
TP53 P04637 1/20 0.64
HTT P42858 1/20 0.64
PDE4D Q08499 1/20 0.64
PDE3A Q14432 1/20 0.64
RXFP1 Q9HBX9 1/20 0.64
ADORA1 P30542 2/20 0.61
MEN1 O00255 1/20 0.57
SLC28A1 O00337 1/20 0.57
MAP3K7 O43318 1/20 0.57
SLC28A2 O43868 1/20 0.57
GAPDH P04406 1/20 0.57
ADORA3 P0DMS8 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Deoxyadenosine SCHEMBL27615805 1.00 POLB (0.68) POLBHIF1AENPP1P2RY1SMN1; SMN2
Deoxyadenosine SCHEMBL888220 1.00 POLB (0.68) POLBHIF1AENPP1P2RY1SMN1; SMN2
Deoxyadenosine SCHEMBL3410419 1.00 POLB (0.68) POLBHIF1AENPP1P2RY1SMN1; SMN2
Deoxyadenosine SCHEMBL8507956 0.96 POLB (0.66) POLBHIF1AENPP1P2RY1SMN1; SMN2
Deoxyadenosine SCHEMBL27801147 0.95 POLB (0.73) POLBHIF1AENPP1P2RY1SMN1; SMN2
Deoxyadenosine SCHEMBL23982174 0.94 HIF1A (0.71) POLBHIF1AENPP1P2RY1SMN1; SMN2
Deoxyadenosine SCHEMBL5982291 0.94 HIF1A (0.71) POLBHIF1AENPP1P2RY1SMN1; SMN2
Deoxyadenosine SCHEMBL5982298 0.94 HIF1A (0.71) POLBHIF1AENPP1P2RY1SMN1; SMN2
Deoxyadenosine SCHEMBL21637036 0.94 HIF1A (0.71) POLBHIF1AENPP1P2RY1SMN1; SMN2
Deoxyadenosine SCHEMBL193181 0.94 HIF1A (0.71) POLBHIF1AENPP1P2RY1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118109537-A Application of halogenating enzyme in catalytic synthesis of 2' -halogenated nucleoside monophosphate 香港中文大学(深圳) 2024-05-31 CN claimed
US-20220401617-A1 ADHESIVE COMPOSITIONS COMPRISING THERAPEUTICS REVBIO INC (US) 2022-12-22 US claimed
EP-4054548-A1 ADHESIVE COMPOSITIONS COMPRISING THERAPEUTICS RevBio, Inc. (US) 2022-09-14 EP claimed
US-20250049488-A1 DEVICES AND METHODS FOR BONE FIXATION REVBIO INC (US) 2025-02-13 US disclosed
US-20240368682-A1 SYSTEMS AND METHODS FOR CLONAL REPLICATION AND AMPLIFICATION OF NUCLEIC ACID MOLECULES FOR GENOMIC AND THERAPEUTIC APPLICATIONS REDVAULT BIOSCIENCES LP (US) 2024-11-07 US disclosed
EP-4447833-A2 DEVICES AND METHODS FOR BONE FIXATION RevBio, Inc. (US) 2024-10-23 EP disclosed
US-20240180625-A1 IMAGE GUIDED DELIVERY OF COMPOSITIONS AND RELATED METHODS REVBIO INC (US) 2024-06-06 US disclosed
CN-118109537-A Application of halogenating enzyme in catalytic synthesis of 2' -halogenated nucleoside monophosphate 香港中文大学(深圳) 2024-05-31 CN disclosed
US-20230329755-A1 BONE FLAP FIXATION DEVICE REVBIO INC (US) 2023-10-19 US disclosed
WO-2023114440-A2 DEVICES AND METHODS FOR BONE FIXATION RevBio, Inc. (US) 2023-06-22 WO disclosed
EP-4164522-A1 BONE FLAP FIXATION DEVICE RevBio, Inc. (US) 2023-04-19 EP disclosed
CN-1729297-A Preparation of deoxyribonucleotides by enzymatic reduction of ribonucleotides SCINOPHARM SINGAPORE PTE LTD (CN) 2006-02-01 CN disclosed
US-6677140-B2 AMPLIFICATION OF PREFERENTIAL NUCLEOTIDE SEQUENCES; OBTAIN NUCLEIC ACID SAMPLE, INCUBATE WITH PRIMERS AND POLYMERASE, AMPLIFY, RECOVER NUCLEOTIDE SEQUENCES PROMEGA CORPORATION 2004-01-13 US disclosed
US-20020192677-A1 Nucleic acid amplification with DNA-dependent RNA polymerase activity of RNA replicases PROMEGA CORPORATION 2002-12-19 US disclosed
US-6369207-B1 FOR DETECTING NUCLEIC ACID ANALYTE IN A TEST SAMPLE PROMEGA CORPORATION 2002-04-09 US disclosed
US-6090589-A USING CHIMERIC NUCLEIC ACID INCLUDING DNA NUCLEOTIDES AND AN RNA SEQUENCE WHICH CAN BE AUTOCATALYTICALLY REPLICATED PROMEGA CORPORATION (US) 2000-07-18 US disclosed
EP-0519053-B1 NUCLEIC ACID AMPLIFICATION WITH DNA-DEPENDENT RNA POLYMERASE ACTIVITY OF RNA REPLICASES PROMEGA CORP (US) 1997-10-29 EP disclosed
EP-0519053-A4 NUCLEIC ACID AMPLIFICATION WITH DNA-DEPENDENT RNA POLYMERASE ACTIVITY OF RNA REPLICASES 1993-03-31 EP disclosed
EP-0519053-A1 NUCLEIC ACID AMPLIFICATION WITH DNA-DEPENDENT RNA POLYMERASE ACTIVITY OF RNA REPLICASES. PROMEGA CORP (US) 1992-12-23 EP disclosed
WO-1992012261-A1 NUCLEIC ACID AMPLIFICATION WITH DNA-DEPENDENT RNA POLYMERASE ACTIVITY OF RNA REPLICASES PROMEGA CORPORATION (US) 1992-07-23 WO disclosed